Skip to main content
en
Super navigation
Newsroom
The Latest
Press releases
argenx Stories
Downloadable assets
A
A
Main navigation additional
Home
Contact us
Home
Patients
Our commitment
Disease areas
Patient stories
Clinical trials
Patient access
Resources
Pipeline
Our pipeline
Externally Sponsored Research
Partnered programs
Publications
Innovation
Science of collaboration
IIP
Case studies
Academic collaborators
Antibody engineering
Partnering opportunities
Products
Investors
Stock information
Events & Presentations
Financial reports
Shareholder meetings
Corporate governance
Environmental, Social and Governance
AFM filings
SEC filings
Analyst coverage
Careers
Dare to do more
Join argenx
Benefits
Employee stories
Newsroom
The Latest
argenx stories
Press releases
Downloadable assets
About
One Team
Cultural Pillars
Management Team
Board of Directors
Grants
Ethics and Responsibility
Contact us
Global websites
Global:
English
Local websites
France:
Français
Germany:
Deutsch
Japan:
日本語
Netherlands:
Nederlands
Spain:
Español
United Kingdom:
English
United States:
English
Secondary navigation additional
Contact
Secondary/mobile navigation
Home
Patients
Our commitment
Disease areas
Patient stories
Clinical trials
Patient access
Resources
Pipeline
Our pipeline
Externally Sponsored Research
Partnered programs
Publications
Innovation
Science of collaboration
IIP
Case studies
Academic collaborators
Antibody engineering
Partnering opportunities
Products
Investors
Stock information
Events & Presentations
Financial reports
Shareholder meetings
Corporate governance
Environmental, Social and Governance
AFM filings
SEC filings
Analyst coverage
Careers
Dare to do more
Join argenx
Benefits
Employee stories
Newsroom
The Latest
argenx stories
Press releases
Downloadable assets
About
One Team
Cultural Pillars
Management Team
Board of Directors
Grants
Ethics and Responsibility
Contact us
Breadcrumb
Home
Investors
Stock Information
X
Facebook
LinkedIn
WhatsApp
Stock Information
View more
